Filter
Showing 16–30 of 68 results
Participants will gain the capability to interpret EU MDR requirements, design regulatory pathways for CE marking, prepare compliant technical documentation, and manage post-market obligations for medical devices in the European market.
Participants will gain the ability to design risk-based audit programs, conduct internal and supplier audits, evaluate findings, and implement effective CAPA systems to strengthen quality compliance.
Participants will gain the ability to establish quality controls for clinical investigations, evaluate study documentation for compliance, and support inspection readiness under ISO 14155 requirements.
Participants will gain the ability to prepare for regulatory inspections, evaluate compliance gaps, manage audit interactions, and develop corrective and preventive actions following regulatory observations.
Participants will gain the ability to interpret scientific and clinical evidence, develop regulatory documentation across the drug development lifecycle, and translate validated clinical data into compliant product labelling and regulatory submissions.
Participants will gain the ability to perform strategic reviews of medical and regulatory documents, identify quality gaps, ensure consistency across complex documentation, and strengthen compliance with regulatory writing standards.
Strategic Pharma Costing & Pricing Excellence
Participants will gain the ability to analyze pharmaceutical cost structures, design strategic pricing models for different markets, and balance profitability with regulatory and market access requirements.
FDA Audit Preparedness: Pharma Operations
Participants will gain the ability to assess audit readiness, identify compliance gaps, manage inspection processes, conduct internal audits, and implement corrective and preventive actions to sustain regulatory compliance.
Global Pharma Landscape: Strategy
Participants will gain the ability to analyze global pharma trends, evaluate business and operating models, assess market opportunities, and develop strategies to drive growth and competitive advantage.
Participants will gain the ability to evaluate non-US pharmaceutical markets, understand regional regulatory pathways, design market entry strategies, and build partnerships that support sustainable international growth for Indian pharmaceutical companies.
Participants will gain the ability to use artificial intelligence tools to support literature analysis, draft scientific and regulatory documents, enhance clarity and consistency in medical writing, and implement responsible workflows that align with pharmaceutical compliance and documentation standards.
Participants will develop the capability to manage end-to-end vaccine tender processes under UIP, ensure regulatory and documentation compliance, optimize bid strategies, mitigate procurement risks, and maintain supply continuity aligned with public health obligations.
Participants will develop the capability to manage end-to-end public procurement processes in the pharmaceutical sector with confidence and compliance. They will understand tender lifecycle management, regulatory alignment, risk mitigation, ethical safeguards, and contract governance—enabling them to execute procurement activities with transparency, accountability, and strategic effectiveness.
participants will be able to interpret global regulatory guidelines, develop regulatory submission strategies, prepare compliant dossiers, manage health authority communications, and ensure inspection readiness across the product lifecycle.
AI Tools Usage for Business Leaders
Participants will be able to navigate the AI tool ecosystem, confidently use leading AI platforms, design integrated AI-driven workflows, evaluate return on investment and implementation feasibility, deploy AI solutions across teams with structured governance, apply security and compliance best practices, and measure tangible business impact in terms of productivity, quality, and cost efficiency.